Our institution operates a 16-bed NSICU with a team of critical care physicians, critical care fellows, and nurse practitioners and a 1:2 nursing-to-patient ratio. Our SDU is a 4-bed unit with a 1:4 nursing-to-patient ratio. Because of the trend toward the regionalization of SAH care and changing referral patterns in our hospital network, there has been a dramatic increase in the number of SAH patients transferred to our center in recent months. In response to this, an SDU transfer protocol was introduced to streamline patient care for patients meeting low-risk criteria beginning on January 1, 2015. For this retrospective study, we hypothesized that our SDU transfer protocol for select, low-risk SAH patients is safe and feasible, and it reduces ICU utilization.
Methods

Study Population
The retrospective study protocol and a waiver of consent were approved by our institutional review board.
All patients admitted to the NSICU with a diagnosis of SAH (ICD code 430) between January 2011 and September 2016 were screened for this retrospective study. January 2011 was chosen as the start date of the study, as this is when the electronic medical record system was initiated at our institution (Mount Sinai Hospital). Patients with SAH of nonaneurysmal etiology were excluded from the study, as were patients who died within 72 hours of admission. Patients were divided into 2 groups based on the date of the transfer protocol implementation (January 1, 2015) . Those who were admitted prior to this date were categorized as the control group. Those admitted afterward were categorized as the "intervention group." Age, sex, comorbid medical conditions, Glasgow Coma Scale (GCS) score, Hunt and Hess grade, and modified Fisher grade were recorded at the time of admission. 3, 4 Aneurysm characteristics and treatment were collected. Dates identifying transfers to and from the NSICU, SDU, and ward were gathered from the medical record, as were the dates of discharge and the location of discharge. Hospital course complications were also obtained from the medical record.
Transfer Procedure
Patients in the control group (i.e., prior to the intervention) followed the previously established practice of remaining in the NSICU for the duration of the vasospasm period (i.e., through Day 14 of admission). Once patients were deemed to be beyond the vasospasm period, a high level of medical stability needed to be reached for transfer to a general ward.
For the intervention group, criteria for transfer to the SDU were assessed daily and included the following: 1) Hunt and Hess Grade III or better, 2) completed diagnostic angiography since admission, 3) aneurysm secured or protected if found, 4) stable neurological examination for longer than 24 hours, 5) no concern for impending symptomatic vasospasm (i.e., elevated or up-trending transcranial Doppler [TCD] ultrasound velocities), and 6) no elevation in intracranial pressure (ICP) for > 24 hours. If each of these criteria were met, patients were deemed eligible for transfer to the SDU. The need for an external ventricular drain did not preclude transfer to the SDU. Management in the SDU included daily TCD measurements and hourly neurological examinations. The NSICU physicians continued to serve as the primary providers for patients in the SDU. If a patient's medical or neurological status worsened or became complicated, the patient was evaluated and, if deemed necessary, transferred back to the NSICU for higher level care. Criteria for transfer back to the NSICU included any of the following: 1) evidence of symptomatic vasospasm, 2) rapidly increasing TCD ultrasound velocities, 3) uncontrolled elevated ICP, 4) neurological deterioration, or 5) general medical deterioration requiring ICU care.
Outcome Measures
There were two primary outcomes for the study. The first primary outcome was safety and feasibility of the SDU transfer protocol, measured by mortality and morbidity of patients transferred to the SDU. The second primary outcome was ICU utilization, measured by NSICU length of stay (LOS). These were chosen as the primary outcome measures to assess whether the transfer protocol clinical criteria were effective in identifying eligible patients for transfer and reducing ICU bed utilization. The secondary outcomes included the following: hospital LOS, mortality rate, 90-day readmission rate, and Glasgow Outcome Scale (GOS) score at discharge. GOS score at discharge was graded based on discharge location: home (Score 5), acute (Score 4), subacute (Score 3), long-term nursing facility (Score 2), and death (Score 1).
Statistical Methods
The marginal comparison of covariates and outcomes between the control and intervention groups was completed using a 2-sample t-test for continuous outcomes and chi-square test for categorical outcomes.
For multivariate analysis, linear regression was applied when continuous variables were used as outcomes, including NSICU LOS, hospital LOS, and average discharge GOS score. Logistic regression was applied when categorical variables were used as outcomes, including hospital mortality rate and readmission rate. Patient inclusion in either the control or intervention group was used as the primary covariate. Age, sex, modified Fisher grade, Hunt and Hess grade, and GCS score, and the presence of medical comorbidities, including coronary artery disease, hypertension, and diabetes mellitus, were also included in the regression models, for adjustment. The p values of the marginal comparisons were calculated to show the crude difference of each variable between the 2 groups. Those variables with a p value < 0.05 were considered to have a significant difference between control and intervention groups. The p value for the primary covariate in each model was generated to indicate the relationship between each outcome and the primary covariate after adjusting by age, sex, modified Fisher grade, Hunt and Hess grade, GCS, and the presence of medical comorbidities, including coronary artery disease, hypertension, and diabetes mellitus. A p value of < 0.05 indicated a significant as-sociation after adjustments. An estimation of the parameters in each model was generated and used to explain the direction of change.
Subgroup Analysis
Patients in the intervention group were split into 3 subgroups: 1) those who were not transferred to the SDU, 2) those who were transferred to the SDU within 7 days of admission, and 3) those transferred to the SDU after 7 days of admission. These groups were analyzed to assess for any differences in 90-day readmission rate. In addition, for those who were transferred to the SDU, early transfer (within 7 days) versus later transfer was assessed for any association with the need to return to the NSICU.
Results
A total of 215 patients were admitted to the Mount Sinai Hospital NSICU with a diagnosis of SAH between January 2011 and September 2016. Patients were excluded because of nonaneurysmal etiology (n = 70) or death within 72 hours of admission (n = 8, 4 patients from each group). After applying exclusion criteria, a total of 137 patients were included, 65 patients before the intervention was implemented (control group) and 72 patients after the transfer protocol was in place (intervention group).
Baseline patient characteristics, including modified Fisher grade, Hunt and Hess grade, age, sex, comorbid conditions, and aneurysm characteristics were not significantly different between the 2 groups, with some exceptions (Table 1) . A greater proportion of patients in the intervention group presented with aneurysms of the posterior circulation. The intervention group was also more likely to have an aneurysm treated by endovascular means than was the control group, which follows the national trend favoring first-line endovascular embolization of ruptured aneurysms. In the intervention group, 79.2% (57/72) of patients were transferred to the SDU during their admission. The average day of transfer to the SDU was Day 9.5 (SD 7.7) of admission. Of the patients transferred to the SDU, 29.8% (17/57) returned to the NSICU during their admission. Of these, 9 patients returned because of suspected symptomatic vasospasm, 5 returned for routine postoperative monitoring following a subsequent procedure (2 for a ventriculoperitoneal shunt and 3 for diagnostic angiography), and 2 returned because of culture-positive CSF infection. There were no emergency or unscheduled returns to the operating room. Additional days spent in the NSICU after return from the SDU were included in the calculated NSICU LOS. Hospital course complications are presented in Table  2 and were not significantly different between the groups.
Unadjusted outcome measures comparing the 2 groups are described in Table 3 . Hospital LOS was significantly longer in the intervention group prior to adjustments for patient demographics, SAH severity measures, and medical comorbidities. Multivariate analysis of outcome measures was applied to adjust for age, sex, modified Fisher grade, Hunt and Hess grade, and Glasgow Coma Scale score, and the presence of medical comorbidities, including coronary artery disease, hypertension, and diabetes mellitus ( Table 4 ). The primary outcome measure, NSICU LOS, was shorter in the intervention group by 1.95 days (95% CI -4.23 to 0.33 days), after adjusting for these covariates, and trended toward significance (p = 0.092). Paradoxically, hospital LOS was longer in the intervention group by 2.7 days (95% CI -0.31 to 5.71), and also trended toward significance after multivariate adjustment (p = 0.080). The mortality rate was lower in the intervention group (5.6% vs 12.3%), although after adjustment the estimated odds of in-hospital death for patients in the intervention group were 0.49 (95% CI 0.11-2.19) times the odds for control group patients and therefore were not significantly different between the groups. The estimated odds of 90-day readmission for intervention group patients were 1.96 (95% CI 0.48-8.01) times the odds for control group patients, after adjustment.
The subgroup analysis of the intervention group revealed no statistically significant differences between the 3 groups (Table 5 ). There was no appreciable difference in 90-day readmission rate for those who were not transferred, those transferred within 7 days of admission, and those transferred after more than 7 days of admission. In addition, there was no statistically significant difference in the rate of return to the NSICU between those transferred within 7 days and those transferred after 7 days of admission.
Discussion
To the best of our knowledge, this is the first study investigating the intrahospital transfer of low-risk patients with nontraumatic SAH to an SDU. Compared with a control population, institution of a transfer protocol to the SDU for low-risk patients with SAH resulted in a reduction in the average NSICU LOS by approximately 2 days. This amounts to an appreciably improved NSICU bed availability, which is of utmost importance, as the care of SAH becomes centralized at high-volume centers. The total hospital LOS, however, was, on average, 2.7 days longer after the institution of the protocol. This dramatic increase may be partially explained by the fact that our medical center saw an increase in the number of patients with SAH transferred to our institution from approximately 30 cases per year prior to January 2015 to about 100 cases per year afterward, which may have contributed to a loss of efficiency. Of the patients transferred to the SDU, 17 (29.8%) required return to the NSICU. However, 5 of these patients returned for routine monitoring following planned procedures and not due to a neurological decline. Among the patients who returned to the NSICU, there were no deaths or morbidity due to care in the SDU. This suggests that despite some patients needing to return to the NSICU, the monitoring in the SDU was appropriate and safe for all patients. Moreover, this suggests that the clinical eligibility criteria that we applied were rigorous and conservative enough to capture only the low-risk patients.
The mortality rate was lower in the intervention group, although the difference was not statistically significant. Nonetheless, this demonstrates that the transfer protocol does not increase the mortality risk. The dichotomized GOS score at discharge was similar between the groups, indicating that the transfer protocol did not appreciably affect clinical outcome. Finally, the 90-day readmission rate was higher in the intervention group (11.1% vs 6.2%), but the difference was not statistically significant, suggesting that it did not appreciably affect long-term complication rates in this patient population.
Subgroup analysis assessing the timing of transfer either before or after 7 days did not reveal any statistically significant difference in need to return to the NSICU or in 90-day readmission rate. This suggests that both early and late transfers to an SDU are equally safe and that, once a patient meets the clinical criteria for transfer eligibility, the process can proceed.
Similar studies evaluating the effectiveness of admitting select low-risk patients to SDUs rather than to ICUs exist primarily in the traumatic brain injury (TBI) literature. Nishijima and colleagues investigated whether traumatic intracranial hemorrhage, including traumatic SAH, could be cared for in non-ICU settings for low-risk patients. 9 The authors categorized patients into high-risk and low-risk groups based on their need for critical care intervention prior to formal admission. Of the 58.4% of patients who were deemed to be low risk, only 3.2% were incorrectly categorized but were safely treated with transfer back to ICU-level care. The authors concluded that low-risk patients could be safely admitted to a non-ICU setting for observation using their selection criteria. Subsequent studies by the same group confirmed these same results in a larger, multicenter retrospective cohort and outlined a clinical decision rule for this patient population. 7, 8, 10 A study by Levy and colleagues built on these results by showing that isolated traumatic SAH in the setting of mild TBI is not associated with poor outcomes and may not require ICU admission. 6 Bardes and colleagues performed a similar study in which patients with mild TBI who met low-risk criteria were cared for in the SDU without repeat imaging rather than in an intensive care setting with serial CT scans.
2 The authors identified alternative criteria that included GCS score, age, and anticoagulant medication use and arrived at the conclusion that select low-risk patients could be safely treated in the SDU setting, echoing previous investigations. 8, 16 Similar findings of safe and cost-effective care in a non-ICU setting have also been reported in low-risk traumatic subdural hemorrhage and after elective neurointerventional procedures. 1, 13 Our study has several limitations. It was conducted retrospectively and is, therefore, subject to the limitations of electronic medical record review. In addition, it was completed at a single center, which limits its applicability, although our medical center serves a large, diverse population and receives transfers from a wide catchment area. Finally, the time periods for the control and intervention groups are, by nature of the study, not matched. It is possible that additional changes to care protocols and personnel may have influenced the results of the study.
Conclusions
This retrospective study demonstrates that a transfer protocol for select low-risk SAH patients from the NSICU to the SDU is feasible, safe, and effective. Further investigation with a large randomized trial is needed to confirm our results. Future research is also needed to identify SDU-transferred patients with a high likelihood of needing to be returned to the NSICU. 
